Increased IL-23 Levels in Psoriatic arthritis tied with Depression and Anxiety
Increased IL-23 Levels in PsA Patients are tied with Depression and Anxiety according to a recent study published in the Clinical Rheumatology
Assessment of serum levels of IL-23 in PsA patients and its correlation with depression, anxiety, and disease activity.
Eighty psoriatic arthritis (PsA) patients and eighty healthy volunteers matched for age and gender were included in this observational case-control study. All participants suspected to a detailed history, clinical assessment, PsA activity using the Disease Activity Index for Psoriatic Arthritis (DAPSA) score, the severity and extent of psoriasis wereStudySerum interleukin assessed by the Psoriasis Area and Severity Index (PASI), and ultrasonographic assessments of the entheses were examined according to the Madrid Sonographic Enthesitis Index (MASEI). Depression and anxiety were assessed by Hospital Anxiety and Depression Scale (HADS). Serum IL-23 was measured and correlated with disease activity, depression, and anxiety.
Results:
- There was no significant difference between patients and controls regarding demographic data. Thirty-six PsA patients (45%) had anxiety and 28 patients (35%) had depression, while in the control group, 16 persons (20%) had anxiety and 12 (15%) had depression, with significant differences between the 2 groups.
- There were significant differences in HADS anxiety and depression scores between patients and controls with significant positive correlations between HADS depression, anxiety scores and IL-23, DAPSA, PASI, and MASEI scores
- IL-23 was positively correlated with DAPSA, PASI, and HADS scores; we observed that interleukin 23, higher DAPSA, and PASI were independently associated with depression and anxiety.
Thus, serum interleukin-23 levels were elevated in PsA patients and were found to be correlated with depression, anxiety, and disease activity.
Reference:
Tabra SA, Abd Elghany SE, Amer RA, Fouda MH, Abu-Zaid MH. Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients. Clin Rheumatol. 2022 Jul 21:1–9. doi: 10.1007/s10067-022-06300-1. Epub ahead of print. PMID: 35861930; PMCID: PMC9301620.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.